Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:01 pm Purchase |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Armistice Capital, LLC | 9,134,817 9.990% |
9,134,817 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 4,731,150 5.100% |
-3,230,997 (-40.58%) |
Filing History |
| 2025-02-12 4:05 pm Purchase |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Caligan Partners LP | 15,856,653 9.990% |
15,856,653 (New Position) |
Filing History |
| 2024-12-09 6:22 pm Purchase |
2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,962,147 8.700% |
862,965 (+12.16%) |
Filing History |
| 2024-11-26 4:15 pm Purchase |
2024-11-22 | 13D | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 52,504,049 49.900% |
37,114,568 (+241.17%) |
Filing History |
| 2024-11-14 09:32 am Sale |
2024-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-6,583,332 (Position Closed) |
Filing History |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,099,182 16.900% |
2,060,199 (+40.89%) |
Filing History |
| 2024-02-14 09:10 am Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
AVORO CAPITAL ADVISORS LLC | 6,583,332 9.990% |
6,583,332 (New Position) |
Filing History |
| 2023-02-14 2:37 pm Purchase |
2022-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 5,038,983 12.300% |
1,428,571 (+39.57%) |
Filing History |
| 2022-07-15 4:15 pm Purchase |
2022-07-05 | 13D | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 15,389,481 37.400% |
4,761,904 (+44.81%) |
Filing History |
| 2022-02-14 4:37 pm Purchase |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 10,627,577 38.600% |
789,830 (+8.03%) |
Filing History |
| 2022-02-14 3:54 pm Purchase |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 3,610,412 13.100% |
200,000 (+5.86%) |
Filing History |
| 2022-02-11 4:57 pm Unchanged |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
ORBIMED ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-01-27 11:04 am Sale |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Davidson Matt | 560,731 2.040% |
-884,272 (-61.20%) |
Filing History |
| 2021-02-16 8:57 pm Purchase |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 3,410,412 13.200% |
3,410,412 (New Position) |
Filing History |
| 2021-02-16 4:04 pm Purchase |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 9,837,747 38.000% |
194,500 (+2.02%) |
Filing History |
| 2021-02-16 3:47 pm Sale |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-3,410,412 (Position Closed) |
Filing History |
| 2021-01-25 5:13 pm Sale |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Davidson Matt | 1,445,003 5.600% |
-1,028,157 (-41.57%) |
Filing History |